AnteoTech’s long-term customer Ellume has secured a $231.8 million agreement with the U.S. Government to support accelerated manufacture of its COVID-19 home test.
Brisbane based AnteoTech Ltd has successfully developed proof-of-concept COVID-19 antigen and Flu A&B point-of-care lateral flow tests that can detect the presence of SARS-Cov-2 and influenza in less than 15 minutes. The tests utilize AnteoTech’s patented